renoprotective

renoprotective

 [re″no-pro-tek´tiv]
protecting the kidney against harmful effects such as of a drug or other chemical.

renoprotective

[re′no-pro-tek′tiv]
protecting the kidney against harmful effects, such as of a drug or other chemical.

renoprotective

(rē″nō-prŏ-tek′tiv) [ reno- + protective]
Protecting the kidneys, structurally or functionally.
Mentioned in ?
References in periodicals archive ?
Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan.
The efficacy of glycemic control as a renoprotective strategy depends on the stage at which it is begun and also depends on the degree of normalization of glucose metabolism.
Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.
In the past two decades, angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor blocker (ARB) have become standard treatment because of their renoprotective effect.
However, there is a plethora of experimental studies that support the notion that UA reduction may not only be renoprotective but may be important in reducing CVD mortality.
ACE inhibition is renoprotective among obese patients with proteinuria.
These data suggest a potential renoprotective effect of canagliflozin treatment in patients with type 2 diabetes at high cardiovascular risk, on top of treatment with angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers," he said.
Discuss the possible renoprotective benefits of SGLT2 inhibitors in patients with type 2 diabetes mellitus.
Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/ HSMS/MSE.
Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy.
2] Recently, Assadi demonstrated that even in children with essential hypertension, the treatment of microalbuminuria by renoprotective therapy (Angiotensin converting enzyme inhibitors or angiotensin-receptor blockers) was associated with regression of left ventricular hypertrophy.